previously authorized for emergency use of remdesivir, as it is now specifically for hospitalized patients with COVID-19. It is recommended for those who require supplemental oxygen, mechanical ventilation, or extracorporeal membrane oxygenation. The FDA has noted that the benefits of remdesivir for treating COVID-19 outweigh any potential risks, making it a valuable addition to the arsenal of medications available for managing severe cases of the disease. The approval of remdesivir represents a significant step in the fight against COVID-19, providing healthcare providers with another tool to help patients recover from the virus.
Source link
FDA Approves Remdesivir, a first for for COVID-19 Treatment
